Oral Iron in Pregnant Women: How Often to Take It and Its Side Effects and Tolerability
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-50
SponsorBnai Zion Medical Center
About this trial
The goal of this prospective observational study is to examine the frequency of gastrointestinal side effects associated with oral iron supplementation during pregnancy. The main question it aims to answer is:
Does intermittent oral iron supplementation result in fewer gastrointestinal side effects compared with daily supplementation in pregnant women? Pregnant women who are prescribed oral iron as part of their routine medical care will take ferrous sulfate on an alternate-day schedule for one week. If no significant gastrointestinal side effects are reported, they will then take ferrous sulfate daily for an additional week and will be followed for one month. Participants will be contacted by the study investigator to report gastrointestinal side effects, and routine blood tests will be used to assess changes in hemoglobin and iron stores.
Eligibility criteria
Qualifiers
Pregnant women aged 18-50
Indication for oral iron treatment as determined by the treating physician, in accordance with standard clinical practice
Baseline iron store levels measured prior to initiation of oral iron therapy
Disqualifiers
Women taking ferrous sulfate 80 mg Tardiferon
Gastrointestinal diseases such as colitis
Women who received intravenous iron during pregnancy
Women who received blood transfusions during pregnancy
Trial design
Treatments tested in this trial
- No intervention. It's an observational study
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov